Hybrid event: Healthcare Innovation & Strategy Series - IP Strategy Beyond Drafting Patents

No items found.
19 October 2021
Tags
No items found.

We would like to invite you to join us for the second part of our life science and medtech event on 09 November where we will continue to explore upcoming trends in IP and healthcare.

This event will highlight the increasing application of microbiome research in many commercial settings. We will also discuss the ever-important topic of performing effective due diligence in life science IP, as well as looking into the specialist areas of IP valuation, online brand enforcement and anti counterfeiting.

Speakers will include experts from EIP and Stobbs. The full schedule is available to view here.

All delegates will leave with key takeaways on the future of IP and healthcare including the risk and opportunities this emerging area offers.

Ready to learn more about the challenges faced by innovators in this exciting sector? Register here.


Related articles

EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
EIP Launches Tech & AI Function to Drive Innovation and Client Excellence
06 November 2025
When it comes to technology, EIP has always been ahead of the curve; we are proud to announce the evolution of our IT department into a dedicated Tech & AI function, marking a bold step towards...
Trade Secrets: Navigating geopolitical risks and IP theft in the semiconductor industry
04 November 2025
Semiconductors have always been a critical technology but have grown significantly in strategic importance in recent years. They have become the key building block in developing and existing markets, including quantum computing, edge computing, AI, IoT, automotive, cellular data technology, smartphones, robotics, and many more. The complex designs and innovations that power semiconductor manufacturing are invaluable both to the world’s economy and technological advancement. Consequently, the semiconductor industry has found itself at the centre of geopolitical tensions, especially between the United States and China. It has become a prime target for cyberattacks and intellectual-property (IP) theft. As such, companies operating in this area must be more vigilant in protecting their intellectual assets.